Protect Chronic Tibial Nerve Stimulator (CTNS) System

Status Terminated

Clinical Trial Summary

30 patient Study. All patients implanted with StimGuard Protect System. Patient followed out to 90 days.

Clinical Trial Description

The proposed therapy is called chronic tibial nerve stimulation (CTNS), which is a low-risk, minimally invasive chronic implant for the treatment of urgency urinary incontinence. CTNS works by the same mechanism as percutaneous tibial nerve stimulation (PTNS), but is provided for chronic use with an implantable device. CTNS treatment involves the placement of a minimally invasive stimulator with an embedded receiver at the tibial nerve. The Protect CTNS System has an external transmitter that activates the implanted stimulator and sends mild electrical pulses to the tibial nerve. These impulses travel to the sacral nerve plexus, the group of nerves at the base of the spine responsible for bladder function. Since stimulation with the Protect CTNS System is chronic it is expected that bladder activity can be changed more quickly and without the frequency of treatments related to PTNS. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02781636
Study type	Interventional
Source	Micron Medical Corporation
Contact
Status	Terminated
Phase	N/A
Start date	April 2016
Completion date	September 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03556891` - Pivotal Study of eCoin for Overactive Bladder With Urgency Urinary Incontinence	N/A
Active, not recruiting	`NCT04936464` - Transcutaneous Tibial Nerve Stimulation for Urgency Urinary Incontinence	N/A
Completed	`NCT04470765` - Transcutaneous Tibial Nerve Stimulation: the ZIDA Device Equivalence	N/A
Recruiting	`NCT05415865` - The Effect of Local Anesthetic Solution in the Bladder Prior to Botox Injections in the Bladder	Phase 3
Recruiting	`NCT05099419` - Repetitive Transcranial Magnetic Stimulation in Women With Overactive Bladder With Urgency Incontinence	Early Phase 1
Recruiting	`NCT05874375` - UCon Treatment of Overactive Bladder (OAB) in Males	N/A
Active, not recruiting	`NCT05241379` - AURA-2: Augmenting Urinary Reflex Activity	N/A
Completed	`NCT02657057` - Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB	N/A
Withdrawn	`NCT00773552` - Solifenacin Succinate Versus Placebo in Inner City Women Ages 20-45 With Overactive Bladder	Phase 4
Recruiting	`NCT04752709` - Efficacy of Surface Electrical Stimulation for Urge Urinary Incontinence in Women	N/A
Recruiting	`NCT03755089` - Oral vs Intravesical Analgesia for Office Bladder Botox Injections	Phase 4
Terminated	`NCT03687164` - Group Medical Visits for Latina Women With Urgency Urinary Incontinence	N/A
Withdrawn	`NCT03697954` - Direct Full-stage Implantation of Sacral Neuromodulation
Completed	`NCT00337558` - A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)	Phase 4
Completed	`NCT03180372` - Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence	N/A
Completed	`NCT05783219` - Lidocaine Patches Prior to Percutaneous Nerve Evaluation	Phase 2
Active, not recruiting	`NCT05308979` - Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial	Phase 4
Completed	`NCT03672461` - A Group-Based Therapeutic Yoga Intervention for Urinary Incontinence in Ambulatory Older Women	N/A
Completed	`NCT01391780` - Pelvic Floor Muscle Evaluation in Women With Stress Urinary and Urgency Urinary Incontinence	N/A
Completed	`NCT03655054` - eCoin for OAB Feasibility Follow-on Study	N/A